List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 266 studies with search of:   "Sorafenib"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Condition: Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Interventions: Drug: sorafenib;   Drug: sorafenib;   Drug: sorafenib and cisplatin;   Drug: sorafenib and cisplatin;   Drug: sorafenib and cisplatin
2 Completed Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)
Conditions: Metastatic Disease;   Renal Cell Carcinoma
Interventions: Drug: Nexavar (Sorafenib);   Drug: Nexavar + IL2
3 Recruiting Sorafenib Gastric Cancer Asian Phase I Study
Condition: Gastric Cancer
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Sorafenib (Nexavar, BAY43-9006);   Drug: Sorafenib (Nexavar, BAY43-9006)
4 Recruiting Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors
Condition: Refractory Malignancy
Interventions: Drug: Capecitabine and Sorafenib;   Drug: Capecitabine and Sorafenib
5 Recruiting A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.
Condition: Carcinoma, Renal Cell
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006);   Drug: Nexavar (Sorafenib, BAY43-9006)
6 Active, not recruiting Randomized Phase IIb Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma (RCC)
Condition: Renal Cell Carcinoma
Interventions: Drug: Sorafenib;   Drug: sorafenib
7 Recruiting Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Sorafenib and Erlotinib;   Drug: Sorafenib
8 Completed Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Drug: CP-4055;   Drug: Sorafenib (Nexavar)
9 Recruiting Sorafenib/Carboplatin/Paclitaxel in Patients With Solid Tumors
Condition: Cancer
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
10 Recruiting Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
Conditions: AML;   Acute Myeloid Leukemia;   Myelodysplastic Disorders
Interventions: Drug: Idarubicin;   Drug: sorafenib;   Drug: Ara-C
11 Not yet recruiting Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine
Conditions: Melanoma Stage III or IV;   No Prior Chemotherapy
Intervention: Drug: Sorafenib (Nexavar), Dacarbazine (DTIC)
12 Completed A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung;   NSCLC
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006);   Drug: Paclitaxel/ Carboplatin
13 Recruiting Sorafenib Long Term Extension Program (STEP)
Condition: Cancer
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
14 Recruiting Sorafenib/Docetaxel Dose Escalation Trial
Condition: Cancer
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
15 Recruiting Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.
Condition: Carcinoma, Renal Cell
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
16 Recruiting Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin
Condition: Cancer
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
17 Active, not recruiting Sorafenib Dose Escalation in Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention: Drug: Nexavar (Sorafenib, BAY43-9006)
18 Recruiting Phase I-II Trial of Sorafenib in Combination With Ifosfamide in Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma
Intervention: Drug: Sorafenib
19 Active, not recruiting A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: Nexavar (Sorafenib, BAY43-9006) + carboplatin + paclitaxel;   Drug: Carboplatin plus Paclitaxel
20 Recruiting Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer
Conditions: Pancreatic Cancer;   Adenocarcinoma of the Pancreas
Interventions: Drug: Gemcitabine, Sorafenib;   Procedure: Radiotherapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services